Fujii K, Odashima S, Okada M
Br J Cancer. 1977 May;35(5):610-4. doi: 10.1038/bjc.1977.95.
Pulse doses of N-dibutylnitrosamine(DBN), N-butyl-N-(4-hydroxybutyl)nitrosamine(BBN) and N-butyl-N-(3carboxypropyl)nitrosamine(BCPN) suspended in 1% gelatin, were administered s.c. to infant CDF1 mice, and the experiment terminated at one year of age. Tumours were induced in lungs and liver. The incidences of lung adenomas were 73-95% in all treated mice, with no sex differences. Hepatocellular adenomas and a carcinoma were found with an incidence of 81% (21/26) in DBN, 59% (13/22) in BBN, and 32% (9/28) in BCPN-treated males and the incidence was 23% (5/22) in DBN-treated females. Only one papilloma of the fore-stomach was induced in mice treated with DBN. These results indicated that the s.c. administration of DBN, BBN, and BCPN induced tumours of the lung and liver, but no tumours of the urinary bladder, under these experimental conditions. The carcinogenic effect on mice at the treated dose level was DBN greater than BBN greater than BCPN.
将悬浮于1%明胶中的脉冲剂量的N-二丁基亚硝胺(DBN)、N-丁基-N-(4-羟基丁基)亚硝胺(BBN)和N-丁基-N-(3-羧丙基)亚硝胺(BCPN)皮下注射给幼年CDF1小鼠,实验在小鼠1岁时终止。在肺和肝脏中诱发了肿瘤。所有接受治疗的小鼠肺腺瘤的发生率为73%-95%,无性别差异。在接受DBN治疗的雄性小鼠中,肝细胞腺瘤和1例癌的发生率为81%(21/26),在接受BBN治疗的雄性小鼠中为59%(13/22),在接受BCPN治疗的雄性小鼠中为32%(9/28),在接受DBN治疗的雌性小鼠中为23%(5/22)。在用DBN治疗的小鼠中,仅诱发了1例前胃乳头状瘤。这些结果表明,在这些实验条件下,皮下注射DBN、BBN和BCPN可诱发肺和肝脏肿瘤,但不会诱发膀胱肿瘤。在处理剂量水平下,对小鼠的致癌作用为DBN大于BBN大于BCPN。